Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Using Dexmedetomidine to Reduce Delirium After Awake Brain Surgery

Official title: Effect of Dexmedetomidine on Postoperative Delirium in Patients Undergoing Awake Craniotomies: a Randomized Controlled Trial

Run by Beijing Tiantan Hospital · NCT05195034 · Data updated 2026-11-12

This study is testing if a medication called dexmedetomidine can help prevent confusion after brain surgery in patients who are awake during the procedure.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment210 (estimated)
SponsorBeijing Tiantan Hospital
Academic / other
Locations1 site (Beijing, Beijing Municipality)
StatusRecruiting
StartedMarch 31, 2022
Main results expectedNovember 30, 2025
Study endsDecember 31, 2025
Registry record updatedFebruary 13, 2025
Trial IDNCT05195034 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are adults aged 18 and older who are scheduled for selective awake craniotomies.

Probably not a fit

Patients with preoperative cognitive impairment, severe bradycardia, or significant hepatic or renal dysfunction may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effect of dexmedetomidine on the incidence of postoperative delirium in patients undergoing awake craniotomies. Given that postoperative delirium is a common complication in this high-risk population, the study aims to determine if dexmedetomidine can effectively reduce its occurrence. Patients will receive either dexmedetomidine or a saline solution during their procedure, and their postoperative cognitive function will be monitored. The findings could provide insights into better management strategies for patients undergoing brain surgery.

Why it matters

Potential benefit: If successful, this study could significantly reduce the incidence of postoperative delirium in patients undergoing awake craniotomies, improving recovery outcomes.

How similar studies have gone: Previous studies have shown that dexmedetomidine may reduce delirium in non-cardiac surgery, but its specific effects on awake craniotomies remain largely untested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients undergoing selective awake craniotomies.
* Age ≥18 years.
* Obtain written informed consent.

Exclusion Criteria:

* 1.Preoperative moderate and severe cognitive impairment (Montreal Cognitive Assessment, MoCA\< 18).
* 2.Preoperative psychotropic medication within one year.
* 3.BMI≤18 or ≥30 Kg/ m2
* 4.Pregnant or lactating women.
* 5.History of traumatic brain injury or neurosurgery.
* 6.Severe bradycardia (heart rate less than 40 beats per minute), sick sinus syndrome or second-to-third degree atrioventricular block.
* 7.Severe hepatic or renal dysfunction.

Where it's running

  • Beijing Tian Tan Hospital, Capital Medical University
    Beijing, Beijing Municipality, China
    Recruiting

Study contacts

  • Principal investigator: Yuming Peng, MD,Ph.D — Beijing Tiantan Hospital
  • Study coordinator: Yuming Peng, MD,Ph.D
  • Email: florapym766@163.com
  • Phone: 8610-59976658

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.